Listen: Nobels for science, biotech dealmaking, & a friendly FTC

What can we learn from mummy DNA? Is Pfizer single-handedly propping up biotech? And how do you get molecules to “click”?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The newest Nobel laureates got their phone calls from Stockholm this week, and STAT science writer Megan Molteni joins us to explain their prize-winning work in medicine and chemistry. We also discuss the latest news in the life sciences, including the state of biotech dealmaking and the evolution of Amylyx Pharmaceuticals.

For more on what we cover, here’s more on the Nobel Prize for medicine; here’s the news on the prize for chemistry; here’s more on Amylyx; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.


Be sure to sign up on Apple Podcasts, Spotify, StitcherGoogle Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Leave a Comment

Your email address will not be published. Required fields are marked *